We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fast and Accurate Diagnostic Test Introduced for Meningitis

By LabMedica International staff writers
Posted on 12 May 2009
A novel, fast-acting multiplex polymerase chain reaction (PCR) diagnostic technique simultaneously verifies a complex range of pathogens that indicate meningitis, a severely debilitating infection that if not diagnosed and treated quickly can result in death.

The Seeplex meningitis ACE detection tests for 12 meningitis-causing pathogens: five bacteria--Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Listeria monocytogenes, and Streptococcus agalactiae; and seven viruses-- Herpes simplex virus 1 and 2 (HSV1, HSV2), varicella zoster virus (VZV, or human herpesvirus 3), Epstein-Bar virus (EBV, or human herpesvirus 4), Cytomegalovirus (CMV), human herpesvirus 6 (HHV6), and enteroviruses from cerebrospinal fluid (CSF).

Traditional methods of diagnosing meningitis rely on culture and Gram staining, both of which have notable performance limitations that can result in inaccurate diagnosis of meningitis. More...
Culture of CSF takes more than three days to obtain test results that can be unclear because of recent antibiotic use, contamination, or fastidious bacteria.

Gram staining is one of the oldest microbiologic tests that distinguish between Gram-positive and Gram-negative bacteria. But Gram staining does not identify the individual strain of bacteria. This type of detailed information is necessary for applying the correct antibiotics that can destroy certain meningitis causing bacteria, and prevent its spread to other people.

The World Health Organization (WHO; Geneva, Switzerland) estimates that 1.2 million cases of bacterial meningitis occur every year around the world, out of which 135,000 are fatal. The WHO postulates that a significant number of viral meningitis infections go undiagnosed in the absence of a standard diagnostic tool to determine the infections.

Seeplex technology is provided by Seegene (Seoul, Korea), a biotechnology company specialized in molecular diagnostics and research applications. "Seeplex Meningitis ACE detection provides accurate, rapid and cost-effective meningitis diagnostics. The test is a clear break from traditional methods of diagnosing meningitis, taking only six hours to detect either bacterial or viral meningitis infection in an easy to use testing format," said Dr. Jong-Yoon Chun, founder and CEO of Seegene. "This test will help to save lives and prevent unnecessary antibiotic prescriptions by providing precise information of meningitis causing pathogens at the earliest possible stage."

Related Links:

World Health Organization
Seegene



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
POC Immunoassay Analyzer
Procise DX
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Immunology

view channel
Image: The testing approach is designed for people with HIV whose viral load rises while taking dolutegravir, aiming to limit the accumulation and spread of drug resistance in resource-limited settings. (Image Credit: Shutterstock)

HIV Monitoring Strategy Uses Drug Levels to Guide Resistance Testing

HIV viral load can rise during antiretroviral therapy for reasons that do not necessarily indicate drug resistance. Clinicians must distinguish between treatment nonadherence and resistance before deciding... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.